GLP-1s and Anesthesia: What Your Surgeon Needs to Know Before Your Procedure

If you're scheduled for surgery while taking a GLP-1 medication, there's a critical safety conversation you need to have with your surgical team — and it needs to happen well before your procedure date. GLP-1 receptor agonists fundamentally alter how your stomach processes food, and this has direct implications for anesthesia safety. Here's what you need to know.

The Core Safety Concern: Pulmonary Aspiration

When you undergo general anesthesia, your normal protective reflexes — including the ability to cough, swallow, and close your airway — are suppressed. If there's food or liquid in your stomach at the time of intubation, it can flow backward into the esophagus and enter the lungs. This is called pulmonary aspiration, and it remains one of the most feared anesthesia complications.

Standard pre-surgical fasting guidelines (nothing to eat for 8 hours, clear liquids up to 2 hours before) are designed to ensure the stomach is empty at the time of anesthesia. These guidelines were developed based on normal gastric emptying rates — and GLP-1 medications change those rates significantly.

GLP-1 receptor agonists slow gastric emptying by 30-50% on average. This means that even after a standard 8-hour fast, a patient on a GLP-1 medication may still have food in their stomach. Multiple case reports and emerging data have documented unexpected residual gastric contents in GLP-1 patients who followed standard fasting protocols.

The ASA Guidance: When to Stop GLP-1 Medications

The American Society of Anesthesiologists (ASA) issued consensus-based guidance that has been updated several times as more data has emerged. As of 2026, the key recommendations are:

For weekly injectable GLP-1 medications (semaglutide, tirzepatide):

• Hold the medication for at least 7 days before elective surgery
• Some anesthesiologists and institutions prefer 2-3 weeks for higher doses, given the dose-dependent effect on gastric motility
• Consider the dose and duration of therapy — higher doses and longer treatment durations are associated with more pronounced gastric emptying delays

For daily oral semaglutide:

• Hold for at least 24-48 hours before surgery — the shorter half-life of the oral formulation means effects clear faster

If the GLP-1 medication cannot be held (e.g., emergency surgery, or the patient didn't know to stop):

• Treat the patient as having a full stomach regardless of fasting duration
• Use rapid sequence intubation (RSI) technique to protect the airway
• Consider point-of-care gastric ultrasound to assess stomach contents before proceeding

Communicating With Your Surgical Team

This is one area where patient advocacy is genuinely essential. The GLP-1 medication landscape has expanded so rapidly that not all surgeons and anesthesiologists are yet fully updated on the implications. Here's what you should proactively communicate:

• The specific GLP-1 medication you take — name, dose, and frequency
• When your last dose was taken — exact date, not "about a week ago"
• Any GI symptoms you're currently experiencing — ongoing nausea, bloating, or fullness may indicate more significant gastric emptying delay

Ideally, this conversation happens during your pre-surgical consultation, not on the day of surgery. Many surgical teams now include GLP-1 status in their pre-operative screening questionnaires, but if yours doesn't, bring it up.

The Gastric Ultrasound Option

One of the most significant advances in perioperative GLP-1 management is point-of-care gastric ultrasound. This non-invasive bedside technique allows the anesthesiologist to visualize the stomach contents in real time before proceeding with anesthesia.

If the ultrasound shows an empty stomach, the procedure can proceed with standard anesthetic technique. If significant stomach contents are visualized, the team can either postpone the procedure, extend the fasting period, or modify the anesthetic approach to protect the airway.

Not all facilities have providers trained in gastric ultrasound, but its availability is expanding rapidly. If you're having elective surgery and you're on a GLP-1 medication, asking whether gastric ultrasound is available at your surgical facility is a reasonable and proactive question.

Special Considerations by Procedure Type

Endoscopy and colonoscopy: GLP-1 medications can affect bowel preparation quality and gastric emptying, potentially leading to inadequate visualization. Many gastroenterologists now ask patients to hold GLP-1 medications for 1-2 weeks before endoscopic procedures and may use enhanced bowel preparation protocols.

Dental procedures under sedation: Conscious sedation (rather than general anesthesia) poses lower aspiration risk, but patients on GLP-1 medications should still inform their dentist and follow extended fasting guidelines.

Emergency surgery: When surgery cannot be delayed, the anesthesiologist should assume a full stomach and employ protective airway management techniques regardless of fasting status. If you're ever in an emergency medical situation, make sure someone on your team knows you take a GLP-1 medication.